FDA Issues Alert For Recall of IV Solutions
The U.S. Food and Drug Administration (FDA) on July 20 issued an alert stating that Baxter International Inc. has voluntarily recalled both of its 0.9 percent Sodium Chloride Injections (50 mL and 100 mL). According to the company, a particulate matter – identified as an insect – has been found in some of the intravenous solutions (IV). While no adverse events have occurred, injecting an IV that contains a particulate matter could cause a blockage in the blood vessels, resulting in stroke, heart attack or damage to other organs.
Keywords: Myocardial Infarction, Particulate Matter, Pharmaceutical Solutions, Sodium Chloride, Stroke, United States Food and Drug Administration
< Back to Listings